Capricorn Fund Managers Acquires Major Stake in Waystar, Making It Top Holding

In a notable move within the investment landscape, Capricorn Fund Managers has recently established a substantial position in Waystar, a leading healthcare technology company. This acquisition, involving over half a million shares valued at approximately $19.15 million, not only signifies a strong vote of confidence in Waystar's potential but also elevates it to the prime position within the fund's portfolio. The decision appears to be well-founded, given Waystar's consistent financial performance and its innovative cloud-based solutions for healthcare payments.

Capricorn Fund Managers Invests Heavily in Waystar, Securing Top Portfolio Spot

Investment firm Capricorn Fund Managers Ltd. officially reported to the Securities and Exchange Commission on October 17, 2025, that it had initiated a new holding in Waystar. The transaction involved the purchase of 505,122 shares, reflecting an estimated value of $19.15 million based on the average share price during the third quarter of 2025. This strategic investment now represents 6.4% of Capricorn Fund Managers' 13F reportable assets under management, making Waystar its largest holding by market value. As of October 16, 2025, Waystar's shares were trading at $36.81, marking a 34% increase over the preceding year and surpassing the S&P 500's performance by 20 percentage points over the same period. Waystar, established in 2017 and headquartered in Lehi, Utah, specializes in providing cloud-based software platforms that streamline healthcare payment processes, including financial clearance, patient care, claims management, and revenue optimization, primarily serving healthcare organizations.

This significant investment by Capricorn Fund Managers highlights a strategic endorsement of Waystar's business model and its future prospects. The company's consistent revenue growth, strong balance sheet, and reasonable forward price-to-earnings ratio make it an attractive long-term investment. This development suggests that investors are increasingly recognizing the value of innovative healthcare technology solutions in optimizing financial operations within the healthcare sector.